Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/Lymphoma
| Status: | Completed |
|---|---|
| Conditions: | Blood Cancer, Lymphoma, Leukemia |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 2 - 18 |
| Updated: | 4/21/2016 |
| Start Date: | July 2004 |
| End Date: | June 2006 |
The hypothesis of the study is that propofol-fentanyl sedation for lumbar punctures in
children with acute leukemia/lymphoma results in fewer adverse events than propofol sedation
alone. Secondary hypotheses state that propofol-fentanyl sedation results in a better
sedation induction, recovery profile and is preferred by patients/families. The study is a
double blind, randomized, placebo controlled crossover study. Following the induction phase
of chemotherapy, children will be randomized in a crossover manner to receive either
fentanyl-propofol or propofol-placebo for future lumbar punctures. Patients will be studied
on two separate occasions, once with propofol-placebo (normal saline) and once with
propofol-fentanyl. Children will be monitored continuously by pulse oximetry,
electrocardiogram (ECG) and direct nursing and physician observation during the sedation in
accordance with the University of Wisconsin (UW) Pediatric Policy and Procedure. Propofol
will be titrated to a Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) score of ≤
7 for all children. Oxygen saturation, respiratory rate, heart rate and blood pressure will
be recorded every 3 minutes by a study investigator during sedation.
children with acute leukemia/lymphoma results in fewer adverse events than propofol sedation
alone. Secondary hypotheses state that propofol-fentanyl sedation results in a better
sedation induction, recovery profile and is preferred by patients/families. The study is a
double blind, randomized, placebo controlled crossover study. Following the induction phase
of chemotherapy, children will be randomized in a crossover manner to receive either
fentanyl-propofol or propofol-placebo for future lumbar punctures. Patients will be studied
on two separate occasions, once with propofol-placebo (normal saline) and once with
propofol-fentanyl. Children will be monitored continuously by pulse oximetry,
electrocardiogram (ECG) and direct nursing and physician observation during the sedation in
accordance with the University of Wisconsin (UW) Pediatric Policy and Procedure. Propofol
will be titrated to a Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) score of ≤
7 for all children. Oxygen saturation, respiratory rate, heart rate and blood pressure will
be recorded every 3 minutes by a study investigator during sedation.
Inclusion Criteria:
- Children ages 2 years to 18 years with acute leukemia/lymphoma cared for by
physicians in the Division of Hematology/Oncology in the Department of Pediatrics and
receiving sedation for diagnostic/therapeutic lumbar punctures (LPs) in the UW
Pediatric Sedation Program
- Enrollment will occur after the induction phase of chemotherapy.
Exclusion Criteria:
- American Society of Anesthesiology score ≥ 3
- Cardiorespiratory instability
- Allergy to propofol or its components
- Age less than 2 years
- Patients receiving other sedative analgesics
- Patients with an oxygen requirement
We found this trial at
1
site
University of Wisconsin In achievement and prestige, the University of Wisconsin–Madison has long been recognized...
Click here to add this to my saved trials
